In this issue:
Oral orexin receptor-2 agonist in narcolepsy type 1
ICSs improve lung function in children born very preterm
Anti-CD14 treatment for hospitalised COVID-19 pneumonia
Sleep disturbance and dyspnoea/lung function after hospitalisation for COVID-19
Postextubation HFNC vs. NIV in obesity
ICSs and Moraxella catarrhalis risk in COPD
Novel PDE-3/4 inhibitor for COPD
Icenticaftor (CFTR potentiator) for COPD
Adverse outcomes with elevated lactate in COPD exacerbations
Please login below to download this issue (PDF)